Archive

5 posts

Filters: tag: IARC Group 2B Clear

The Anti Radiation Case That Refuses to Sell a Number

Independent Voices RF Safe Jan 16, 2026

RF Safe argues that many “anti-radiation” phone cases market misleading “% blocked” claims based on lab material tests rather than whole-device, real-world performance. The article promotes RF Safe’s TruthCase/QuantaCase as a “physics-first” design that avoids advertising a single blocking percentage and emphasizes…

Unmasking the Hidden Dangers of Your Phone’s Invisible Waves

Independent Voices RF Safe Dec 10, 2025

RF Safe argues that radiofrequency (RF) emissions from phones and Wi‑Fi pose non-thermal biological risks and that current safety limits are outdated. The post cites animal studies (including NTP and Ramazzini) and references WHO and IARC positions while promoting a proposed mechanism framework (“S4‑Mito‑Spin”) and…

Evidences of the (400 MHz - 3 GHz) radiofrequency electromagnetic field influence on brain tumor induction.

Research RF Safe Research Library Jan 1, 2022

This review discusses whether radiofrequency electromagnetic fields (400 MHz–3 GHz), particularly from mobile phones, influence brain tumor induction. The abstract describes epidemiological evidence as supporting a causal association, highlighting statistically significant ipsilateral tumor findings. It also claims…

[Cell Phones, Radio Frequencies (RF) and Health: IARC classification and epidemiological updates].

Research RF Safe Research Library Jan 1, 2020

This narrative review synthesizes evidence up to September 2019 on health risks from radiofrequency exposure emitted by mobile phones, in the context of IARC's 2013 Group 2B classification. The authors report that the literature does not show a clear risk profile and cannot definitively confirm or refute a health…

Decreased survival of glioma patients with astrocytoma grade IV (glioblastoma multiforme) associated with long-term use of mobile and cordless phones

Research RF Safe Research Library Oct 16, 2014

This analysis examined survival among 1678 glioma patients from two case-control study periods (1997–2003 and 2007–2009) in relation to wireless phone use. In the >20 years latency group, the authors report increased hazard ratios for glioma overall and for astrocytoma grade IV (glioblastoma multiforme), with hazard…

Page 1 / 1